Synthesis, Conformational Analysis, and Biological Evaluation of Heteroaromatic Taxanes

The asymmetric syntheses of heteroaromatic 3-[(tert-butyldimethylsilyl)oxy]-2-azetidinones 12−16 via chiral ester enolate−imine cyclocondensation chemistry are described. The azetidinones contain heteroaromatic moieties which, in certain cases, contribute to a decrease in enantioselectivity due to p...

Full description

Saved in:
Bibliographic Details
Published inJournal of organic chemistry Vol. 61; no. 8; pp. 2664 - 2676
Main Authors Georg, Gunda I, Harriman, Geraldine C. B, Hepperle, Michael, Clowers, Jamie S, Vander Velde, David G, Himes, Richard H
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 19.04.1996
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The asymmetric syntheses of heteroaromatic 3-[(tert-butyldimethylsilyl)oxy]-2-azetidinones 12−16 via chiral ester enolate−imine cyclocondensation chemistry are described. The azetidinones contain heteroaromatic moieties which, in certain cases, contribute to a decrease in enantioselectivity due to possible alternate coordinations in the transition states. The (3R,4S)-3-[(tert-butyldimethylsilyl)oxy]-4-heteroaryl-2-azetidinones were subsequently converted to the heteroaromatic taxanes 31−36 and 43−45. Conformational analyses of the 3‘-(2-pyridyl) analogue 31 and 3‘-(2-furyl) analogue 43 indicate they have solution conformational preferences virtually identical to paclitaxel and docetaxel. Heteroaromatic N-acyl paclitaxel analogues 47−51 were prepared from N-debenzoylpaclitaxel via Schotten−Baumann acylation. The majority of the 14 analogues displayed good to excellent activity in a microtubule assembly assay in comparison to paclitaxel. The analogues were also tested for cytotoxicity against B16 melanoma cells. 3‘-Dephenyl-3‘-(2-pyridyl)paclitaxel (31), 3‘-dephenyl-3‘-(2-furyl)paclitaxel (34), N-BOC-3‘-dephenyl-3‘-(2-furyl)paclitaxel (43), 3‘-dephenyl-3‘-(2-furyl)-N-(hexanoyl)paclitaxel (44), and N-debenzoyl-N-(3-furoyl)paclitaxel (51) were found to be more cytotoxic than paclitaxel against this cell line. 3‘-Dephenyl-3‘-(4-pyridyl)paclitaxel (33) and N-debenzoyl-N-(2-furoyl)paclitaxel (50) displayed cytotoxicity against B16 melanoma cells similar to paclitaxel.
Bibliography:ark:/67375/TPS-72PCSZTR-L
istex:1456FD85ED791F90EF81B83D5841C24597BE0A41
Abstract published in Advance ACS Abstracts, April 1, 1996.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3263
1520-6904
DOI:10.1021/jo951961c